Foghorn Therapeutics Inc. (FHTX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $578.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-134.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $576.06M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-133.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $523.94M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $24.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $521.12M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $24.00K.
Foghorn Therapeutics Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $6.00K | $578.62M | $-134.00K | $-659.53M | $-81.04M | 3 month · $2.55M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $6.00K | $576.06M | $-133.00K | $-652.34M | $-76.41M | 3 month · $2.38M | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $6.00K | $523.94M | $24.00K | $-632.47M | $-108.50M | 12 month · $10.40M | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $6.00K | $521.12M | $24.00K | $-610.80M | $-89.66M | 3 month · $2.73M | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $6.00K | $518.33M | $-44.00K | $-594.95M | $-76.66M | 3 month · $2.73M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $6.00K | $515.35M | $14.00K | $-577.02M | $-61.65M | 3 month · $2.69M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $6.00K | $512.51M | $135.00K | $-558.18M | $-45.53M | 12 month · $11.89M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $6.00K | $510.03M | $360.00K | $-538.68M | $-28.29M | 3 month · $3.02M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $6.00K | $505.57M | $-338.00K | $-519.56M | $-14.32M | 3 month · $3.17M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $4.00K | $399.59M | $-497.00K | $-496.58M | $-97.49M | 3 month · $3.22M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $4.00K | $395.20M | $-826.00K | $-471.56M | $-77.19M | 12 month · $16.19M | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $4.00K | $391.96M | $-1.89M | $-447.46M | $-57.39M | 3 month · $4.09M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $4.00K | $386.48M | $-2.72M | $-433.11M | $-49.35M | 3 month · $4.47M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $4.00K | $381.91M | $-2.87M | $-403.63M | $-24.59M | 3 month · $4.57M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $4.00K | $377.23M | $-3.99M | $-373.14M | $112.00K | 12 month · $14.34M | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $4.00K | $373.44M | $-4.86M | $-344.25M | $24.32M | 3 month · $3.80M | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $4.00K | $369.30M | $-3.19M | $-318.48M | $47.63M | 3 month · $3.51M | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $4.00K | $364.76M | $-1.19M | $-291.17M | $72.40M | 3 month · $3.24M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $4.00K | $361.13M | $-10.00K | $-264.26M | $96.87M | 12 month · $8.38M | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $4.00K | $316.10M | $-13.00K | $-235.11M | $80.98M | 3 month · $2.37M | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $4.00K | $313.23M | $-10.00K | $-209.03M | $104.19M | 3 month · $2.04M | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $4.00K | $311.08M | $6.00K | $-185.92M | $125.16M | 3 month · $1.89M | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $4.00K | $309.13M | $-7.00K | $-162.94M | $146.19M | 12 month · $2.96M | (m) | 12 month · $188.00K | 12 month · $114.00K |
| 2020-09-30 | (m) | $1.00K | $8.85M | (m) | $-142.18M | $-133.32M | 3 month · $877.00K 9 month · $1.88M | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-116.41M | 3 month · $489.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-101.20M | 3 month · $517.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $6.12M | (m) | $-94.14M | $-88.02M | 12 month · $1.69M | $86.54M | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $-73.79M | 3 month · $443.00K 9 month · $1.12M | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-61.28M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-39.27M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |